Commercial Medical Devices

Veeva MedTech Summit: AI Readiness Rests on Data, Governance and Human Judgment

Ravi MenonNovember 8, 20265 min read1 views

At a glance

  • Conference discussions focused on how medical technology firms can prepare for AI by fixing foundational data and process issues, embedding risk-based governance and preserving expert oversight.
  • At the Veeva MedTech Summit in Amsterdam, Medtronic and other speakers said AI adoption in medical technology depends less on speed than on reliable data, consistent processes, proportionate governance and human oversight. They highlighted pilot-led value assessment and closer collaboration among IT, quality and regulatory teams.
A conceptual cutaway shows layered data pipelines and process blocks supporting a medical device, with an abstract supervisor reviewing an AI recommendation under governance rails.

Artificial intelligence is moving into medical technology workflows ranging from regulatory processes to information access and operations, but discussions at the Veeva MedTech Summit in Amsterdam focused on a prior question: whether companies have the foundations to use it reliably.

The conference message was that successful digital transformation depends on reliable data, consistent processes, appropriate governance and people able to oversee them. Without those elements, introducing AI into fragmented environments can create more problems than it solves, leaving outputs that are difficult to trust, validate or scale.

Medtronic’s four-year groundwork

Becki Brasher of Medtronic described the company’s four-year effort to prepare for AI. Rather than starting with the technology, Medtronic harmonised processes, improved data consistency, consolidated systems and established governance structures. Brasher said the company did not start with AI and had to earn it.

Her presentation also stressed employee preparation. Technology alone cannot deliver transformation; staff need knowledge, confidence and oversight to incorporate new tools into daily work.

Governance from the outset

In the closing keynote, Erik Orzechowski and Benjamin Rochette argued that governance should be built into technology development from the start, not treated as a final compliance exercise. They said closer collaboration between IT, quality and regulatory teams is needed: IT understands implementation, while quality and regulatory specialists assess risks and define the evidence required for compliance.

The speakers also called for proportionate governance. An AI application supporting low-risk administrative work need not face the same controls as one influencing patient safety or regulatory decisions. Clear responsibilities, early risk assessments and appropriate controls can support innovation while preserving obligations, they said. Compliance and innovation should not be treated as opposing priorities.

Human judgment and trust

Despite AI’s growing capabilities, the summit highlighted the continuing role of human expertise. Brasher said AI should assist human reviewers rather than replace them, and that human judgment will remain essential until organisations build trust that AI agents deliver accurate results.

AI can analyse large volumes of information, generate documentation and make recommendations, but its outputs still require scrutiny. A convincing answer is not necessarily correct, particularly in a regulated environment. The closing keynote compared relying on AI without understanding its subject matter to using a calculator without knowing the mathematics behind it.

That raises a workforce question: if employees rely on AI before developing underlying knowledge, companies could have fewer people able to challenge inaccurate or inappropriate recommendations. The consensus was that AI should complement human expertise, with accountable individuals retaining responsibility for important decisions.

Pilot-led value and adaptation

Organisations also need to show that AI investments deliver business value. With many possible applications, the speakers advised against pursuing every opportunity at once. Instead, companies should target existing operational challenges and define success measures such as time savings, shorter process cycle times, less rework, improved quality and employee adoption.

Controlled pilots can show where AI is most effective, preserve human oversight and build confidence before wider deployment. Because the technology and regulatory expectations will keep changing, governance structures need to adapt alongside new capabilities.

The summit’s conclusion was that success will depend less on the number of AI initiatives launched than on the ability to turn promising applications into reliable, scalable capabilities. Orzechowski described the need to “slow down to speed up”—a phrase the report attributed to him—by getting foundations right today.

Reported by Ravi Menon, Respiratory and Life-Support Systems Analyst.